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Two new collagen-like loci have been identified in the human genome which have sequence similarity to the triple-helical coding region of the 
pro-~2(I) gene. Both loci exhibit length polymorphism due to alleles that contain deletions. The deletion at one locus is 400 bp while the deletion 
at the second locus is 200 bp. The second locus is on chromosome 17 and its two alleles are not in Hardy-Weinberg equilibrium. These loci are 
candidates for involvement in connective tissue disorders. 
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1. INTRODUCTION 
The collagens are a large family of proteins which are 
essential components of extracellular matrices. At least 
14 genetically distinct collagen types have so far been 
identified, many of which are heterotrimers [1]. Thus, 
more than 20 genes in the human genome are involved 
in encoding these proteins [1]. While the functions for 
many of the collagens are not yet well-understood, the 
major fibrillar collagens Types I, II and III have been 
extensively studied [1]. 
Defects in the structural genes for the fibrillar colla- 
gens are now known to be involved in several of the 
heritable disorders of connective tissue [2,3]. A number 
of restriction fragment length polymorphisms (RFLPs) 
have been found to be associated with each of these 
collagen genes. In the case of the genes for Type I colla- 
gen, RFLPs have already proven useful in following the 
inheritance of some forms of diseases like osteogenesis 
imperfecta and Ehlers-Danlos syndrome [4]. The major- 
ity of fibrillar collagen gene RFLPs identified to date 
are the result of base substitutions that change a restric- 
tion enzyme site [4]. There have been only a few reports 
of length polymorphisms due to insertion/deletions at 
human fibrillar collagen gene loci [5,6]. Here we de- 
scribe two previously-undetected collagen-like loci 
which both exhibit length polymorphism and which 
could be involved in connective tissue disorders. 
2. MATERIALS AND METHODS 
Twenty ml peripheral b ood samples were obtained from individuals 
having no personal or family history of connective tissue disorders. 
DNA was isolated from the whole blood by a standard procedure [7], 
*Corresponding author. Fax: (1) (312) 508-3646. 
which we have modified. The modifications involve using spermine 
precipitation of the DNA [8], rather than ethanol precipitation, and 
omitting RNase treatment of the sample. We find that these changes 
improve the yield of DNA and reproducibly give samples lacking 
restriction enzyme inhibitors. The yield from each 20 ml of blood is 
at least 200/,tg. Normal placental DNA was purified as previously 
described [9]. 
Our described methods were used for restriction digests and gel 
electrophoresis [10,11]. The DNA was transferred from the gel by the 
alkaline method [12] onto Gene Screen Plus membranes (NEN). 
cDNA probes were cut by restriction enzymes to release the inserts 
from the vector and then 32p-labelled by nick translation as described 
[10,13]. Membranes were pre-hybridized at 37°C for 5 h in hybridiza- 
tion solution (50% formamide, 1 M NaCI, 50 mM Tris pH 7.5, 1% 
SDS, 10/lg/ml denatured E.coli DNA). Denatured labelled probe was 
added and hybridization took place at 37°C for 16 h. Membranes were 
then given two 10 rain washes at room temperature in 2 x SSC 
(1 × SSC is 150 mM NaC1, 15 mM sodium citrate, 0.1 mM EDTA), 
followed by two 30 min washes at 60°C in 2 x SSC plus 1% SDS and 
two 30 min washes at room temperature in 0.5 × SSC. For the 
CosHcoll probe, which contains repetitive sequences, the hybridiza- 
tion temperature was 55°C with denatured human placental DNA 
added to the hybridization mixture at 30 ¢tg/ml. The second two sets 
of washes were in 0.5 × SSC plus 1% SDS at 65°C and in 0.1 x SSC 
at room temperature. Autoradiography of the membranes took place 
as described [10]. 
3. RESULTS AND DISCUSSION 
In the course of other studies, the pro-~2(I) cDNA 
probe Hf32 [14] was used to examine the collagen gene 
structure in a number of normal individuals. Two previ- 
ously-undescribed length polymorphisms were found. 
An example of one of the polymorphisms (Site 1) is 
shown in Fig. 1, where an individual has, instead of the 
usual 7.4 kb HindlII fragment, both a 7.0 kb and 7.4 kb 
fragment, both of which are present in about half the 
amount as the 7.4 kb HindlII fragment found in most 
individuals. Similarly, this same individual has both a 
2.6 kb and a 3.0 kb PstI fragment instead of just the 
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Fig. 1. Length polymorphism at Site 1. DNAs from two individuals 
were digested with PstI (lanes 1 and 2) or HindlI1 (lanes 3 and 4). 
DNAs from five other individuals were digested with PstI (lanes 5-9). 
All were probed with the pro-~2(I) eDNA clone Hf32 [14]. The frag- 
ment sizes in kb are indicated. Note the heterozygous polymorphism 
of the 3.0 kb PstI fragment and the 7.4 kb HindlII fragment (lanes 1 
and 3) and the homozygous polymorphism ofthe 3.0 kb PstI fragment 
(lane 6). 
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Fig. 2. Length polymorphism at Site 2. DNAs from two individuals 
were digested with PstI (lanes 1 and 2) or HindlII (lanes 3 and 4). 
DNAs from two other individuals were digested with HindIII (lanes 
5 and 6). All were probed with Hf32. The fragment sizes in kb are 
indicated. Note that one individual is heterozygous for the length 
polymorphism (lanes 1 and 3) and another individual is homozygous 
(lane 5). 
usual 3.0 kb fragment. Again both of these fragments 
are present in about half the amount as the 3.0 kb 
fragment present in most individuals. Such complemen- 
tary results with more than one restriction enzyme dem- 
onstrate that the polymorphism at Site 1 is due to a 400 
bp deletion. The individual in question is thus heterozy- 
gous for this deletion, and examples of homozygotes for 
the deletion have also been observed (Fig. 1). 
Examples of the second polymorphism (Site 2) are 
shown in Fig. 2. Here, instead of the usual 4.6 kb 
HindIII fragment, both a 4.4 and a 4.6 kb fragment are 
seen. Similarly, both a 5.0 and a 5.2 kb PstI fragment 
are present, instead of just the usual 5.2 kb PstI frag- 
ment. Again, when the two fragments are found, they 
are each present in about half the amount as the usual 
full-sized fragment. These results indicate the presence 
of 200 bp deletions at Site 2, and both homozygotes and 
heterozygotes for the deletion have been observed 
(Fig. 2). 
Twenty individuals were examined at Site 1, and 15 
were found homozygous for the large (non-deleted) al- 
lele, 4 were heterozygous, and 1 was homozygous for 
the small allele. Thus, the frequency for the small allele 
is 0.15 + 0.06, and the two alleles are in Hardy-Wein- 
berg equilibrium (P > 0.7). At Site 2 there were 14 indi- 
viduals homozygous for the large allele, 2 heterozygo- 
tes, and 4 homozygous for the small allele. The fre- 
quency for the small allele at Site 2 is thus 0.25 + 0.07. 
Interestingly, the alleles at Site 2 are not in Hardy- 
Weinberg equilibrium (P < 0.006) due to an unexpect- 
edly low frequency of heterozygotes. Given the sample 
sizes, the Yates correction was used in determining 
Hardy-Weinberg equilibria. 
The fragments at Sites 1 and 2 are detected with a 
pro-~2(I) eDNA probe, but the restriction map of the 
COL1A2 gene does not contain the 7.4 kb HindlII and 
3.0 kb PstI fragments characteristic of Site I nor the 4.6 
kb HindllI and 5.2 kb PstI fragments characteristic of 
Site 2 [15,16,17]. COL1A2 genomic lones that span the 
same region of the gene as does the eDNA were used 
to probe samples where the eDNA probe had detected 
length polymorphisms atSites 1 or 2 (Fig. 3). In no case 
did the genomic clones detect he usual-sized or dele- 
tion-containing restriction fragments characteristic of 
either Sites 1 or 2. The fragments containing Site 2 are 
similar in size to ones found in COL1A2, but by sequen- 
tially hybridizing the same blot with the eDNA probe 
and then the genomic lones we clearly demonstrated 
that the restriction fragments characteristic of Site 2 are 
distinct from those in COL1A2 (Fig. 3). Thus the pro- 
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Fig. 3. Absence of length polymorphism in COL1A2. DNAs from 
three individuals were digested with PstI (lanes 1 3) or HindllI (lanes 
4-6) and hybridized with the COL 1 A2 genomic lone N J-3 [15]. Lanes 
1 and 5 contain a sample in which Hf32 detected a homozygous 
deletion at Site 2. This same filter had previously been hybridized with 
Hf32. Note the lack of any length polymorphism in this sample when 
probed with N J-3. Similarly, no polymorphism was detected when the 
N J-1 genomic lone of COL1 A2 [15] was used as probe. The fragment 
sizes in kb are indicated. 
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Fig. 4. Absence of the deletion sites in other collagen genes. (A) DNAs 
from three individuals where length polymorphisms were found with 
Hf32 were digested with PstI (lanes 1-3) or HindlII (lanes 4-6) and 
probed with the COL1AI cDNA Hf404 [24]. Note the absence ofany 
polymorphisms with this probe. Similarly, no polymorphisms were 
detected with the Hf677 eDNA probe for COL1A1 [24]. (B) DNAs 
from three individuals where length polymorphisms were detected 
with Hf32 were digested with PstI and probed with the CosHcoll 
cosmid clone for the full COL2A1 gene [25]. No length polymorphisms 
are detected. Sizes in kb of selected fragments are indicated. 
~2(I) cDNA must be able to hybridize under our condi- 
tions to sequences besides those in COL1A2, and Sites 
1 and 2 must be in a pro-~2(I)-like genetic region(s) 
other than COL1A2. Since the COL1A2 gene is primar- 
ily made up of very short exons (usually less than 100 
bp) [15,17] one would not expect he highly intron-inter- 
rupted genomic probes to detect he cross-hybridizing 
new collagen-like loci. The restriction fragments of both 
sites are detected only by the triple helical coding do- 
main of the eDNA probe (data not shown), so these 
regions do not contain any sequences related to the 
pro-~2(I) carboxy-propeptide. 
We have attempted to determine whether the deletion 
sites are in some other known human fibrillar collagen 
genes, eDNA probes corresponding to the full COL1A1 
gene were used to probe samples where the pro-c~2(I) 
cDNA probe had detected eletions, and again none of 
the deletion-containing restriction fragments character- 
istic of Sites 1 or 2 were detected (Fig. 4A). A genomie 
cosmid clone for the full COL2A1 gene (Fig. 4B) and 
cDNA probes for the full COL5A2 [18] and COL3A1 
[19] genes similarly detected none of the deletion-con- 
taining fragments (not shown). Thus, Sites 1 and 2 are 
not in these other collagen genes, but are likely in one 
or more still-undescribed genes closely related to 
COL1A2. At least for Site 2, its chromosomal localiza- 
tion also rules out its being in any of the other known 
fibrillar collagen genes (see below). 
A human-hamster somatic ell hybrid panel was used 
to identify the chromosome(s) carrying Sites 1 and 2. 
Site 2 was localized to chromosome 17 (Fig. 5). Site 1 
has not yet been localized due to the fact that the ham- 
ster genome contains restriction fragments of similar 
size to those containing Site 1 that also cross-hybridize 
with the pro-~2(I) cDNA (Fig. 5). The only other 
known collagen gene on chromosome 17 is COL1A1 [2], 
and, as shown above, Site 2 is not in that gene. All other 
known human collagen genes have been localized to 
chromosomes other than 17 [2]. This provides addi- 
tional evidence that Site 2 is not in an already-character- 
ized collagen gene. 
The majority of fibrillar collagen gene RFLPs identi- 
fied to date are the result of base substitutions [4]. There 
have been only a few reports of length polymorphisms 
at human fibrillar collagen gene loci. A 38 bp insertion/ 
deletion is a common polymorphism within an intron 
of the COL1A2 gene [5], and a region adjacent o the 
3" end of the COL2A1 gene exhibits a high degree of 
length polymorphism due to variation in the number of 
copies of a simple tandemly repeating sequence [6,20]. 
The COL3A1 gene contains a polymorphic block of 
dinucleotide repeats in one intron [21]. Recently a chro- 
mosome 11 locus containing some uncharacterized col- 
lagen-like sequences has been shown to have substantial 
length polymorphism arising from variable numbers of 
a tandem repeat [22]. However, the properties of this 
locus clearly distinguish it from the two polymorphic 
sites we have described here. 
Thus, the two collagen-like sites identified are not in 
any previously-described loci, and, at this point, it is not 
known whether both sites are in the same gene. Based 
on the length polymorphisms described above for other 
human collagen loci, it is likely that these new deletion 
sites are in introns or other non-coding regions. Of par- 
ticular interest is the fact that at least at one of the sites 
the alleles are not in Hardy-Weinberg equilibrium, indi- 
cating that the locus produces a product and that some 
genotypes can lead to a detrimental phenotype. Since 
the short allele is found in phenotypically unaffected 
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Fig. 5. Identifying the chromosome carrying deletion Site 2. The indi- 
cated DNAs from a human-hamster somatic cell hybrid panel (Bios 
Corp., New Haven) were digested with HindllI and hybridized with 
the Hf32 probe. Representative hybrid DNAs from the chromosome 
panel are shown. Lanes: 1, total human DNA; 2, hybrid cell DNA 
containing neither chromosomes 7 or 17; 3, hybrid cell DNA contain- 
ing chromosome 7; 4, hybrid cell DNA containing chromosome 17. 
Sizes in kb of selected fragments are indicated. The 4.6 kb fragment 
characteristic of Site 2 is only found in hybrid cells containing chromo- 
some 17. The 5.9 and 3.3 kb fragments from the COL1A2 gene map 
to chromosome 7 as previously shown [26]. 
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individuals,  it suggests that the delet ion serves as a 
marker  for an allele that is not  itself harmful ,  but  that 
predisposes to detr imenta l  phenotypes.  Such alleles in 
the unaffected popu la t ion  have been found to be in- 
volved in fragile X syndrome and myoton ic  dystrophy 
[23], These two new col lagen-l ike sites should therefore 
be examined for their possible invo lvement  in var ious 
connect ive tissue disorders. The po lymorph ic  nature  of  
the sites may prove useful in this analysis. 
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